# Antaike Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antaike-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $15M
- Latest round: Series C (Jun 17, 2022)
- Investors on record: 8

## About

Based in Shanghai, China and established in 2017, Antaike Medical is a medical technology company that engages in the research and development of minimally invasive interventional treatment of atrial fibrillation medical equipment. The company's co-founder and general manager is Wei Xue.

The company's main products are cryoballoon ablation products and PFA (Pulsed Electric Field Ablation) technology platform. Cryoballoon ablation is used for catheter ablation of atrial fibrillation.

## Funding rounds

- Series C, Jun 17, 2022, $15M — Shanghai Zhangjiang Science & Technology Venture Capital, Dingxin Capital, Sunland Capital, Huangpu Pharmaceutical Fund
- Series B, May 26, 2020 — Shanghai Jianyi Private Equity Fund Management, AnlongMed Investment, Dingxin Capital, Shannan Haosheng Investment Management
- Series A, Jun 21, 2019 — Shanghai Jianyi Private Equity Fund Management
- Series A, Dec 11, 2018 — Zhongti Dingxin Capital

## Investors

- Zhongti Dingxin Capital (https://capitalatlas.ai/funds/zhongti-dingxin-capital) — Series A
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series A, Series B
- AnlongMed Investment — Series B
- Dingxin Capital — Series B, Series C
- Shannan Haosheng Investment Management (https://capitalatlas.ai/funds/shannan-haosheng-investment-management) — Series B
- Shanghai Zhangjiang Science & Technology Venture Capital — Series C
- Sunland Capital — Series C
- Huangpu Pharmaceutical Fund — Series C